Dr. Daniel E. Krampitz, MD

Dr. Krampitz practices at Dallas Pediatric Neurology Associates - HOPD in Dallas, Texas.

Dr. Krampitz's NPI, 1104922988, was assigned on September 16, 2006. Dr. Krampitz graduated from University of Illinois College of Medicine - Chicago in 1990. Dr. Krampitz holds Texas license J6149.

Dr. Krampitz's primary practice is Dallas Pediatric Neurology Associates - HOPD, at 8390 Lyndon B Johnson Fwy, Dallas, TX 75243.

Dr. Krampitz's primary practice is Dallas Pediatric Neurology Associates - HOPD in Dallas, Texas. Dr. Krampitz is also affiliated with Texas Health Dallas. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Krampitz to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krampitz practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Krampitz's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Krampitz is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dr. Krampitz is licensed in Texas.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, head injury and hereditary polyneuropathy among the conditions Dr. Krampitz treats.

CMS data shows 713 Medicare services from Dr. Krampitz across 10 procedure codes in 2024, for 327 Medicare patients. Medicare paid $54,560 for them.

CMS counts 327 Medicare patients who saw Dr. Krampitz in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krampitz's median patient age at 70, with 54% women.

In 2024, Dr. Krampitz wrote 1,056 Medicare Part D claims for 186 patients. 94% of them were for generic drugs. CMS names the drug for 868 of them, across 23 drugs with 11 or more claims each, at $144,827 in total drug cost. In 2023, CMS named 822 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Krampitz for performance year 2024, reported as part of a group. Dr. Krampitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Krampitz. The most frequent topics are Muscle Cramp. Dr. Krampitz's most frequent co-author is Dennis Kendall Burns, MD.

CMS Open Payments shows 652 general payments to Dr. Krampitz from 69 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,508.

Dr. Krampitz graduated from University of Illinois College of Medicine - Chicago in 1990. Dr. Krampitz is a member of AAN.

Dr. Krampitz is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.